Skip To Main Content
Jason Lester on Muck Rack

Jason Lester

As seen in: NPR, Atlas Obscura, Journal of Medical Case Reports, RTÉ, The Lancet, The Sentinel Colorado, Alive, Rapid Growth, touchONCOLOGY
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jason

Contact Jason, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

High Resolution am 13. Juli 2025 um 02:50 Uhr auf SAT.1 - TVMovie

|
By Jason Lester, Ellie Bamber, Justin Chon, Josh Salatin
| TV Movie
Verfilmung des Kultromans "Taipei" von Tao Lin mit Ellie Bamber und Justin Chon in den Hauptrollen: Die Bloggerin Erin lernt, kurz nachdem ihr Freund Beau mit ihr Schluss gemacht hat, den angesagten Schriftsteller Paul kennen, der ihr Herz im Sturm erobert. Als Paul Erin vorschlägt, jeden Aspekt ihrer Romanze filmisch darzustellen, beginnt eine turbulente Zeit, die von Drogen, Partys und schlaflosen Nächten geprägt ist ...
Open in Who Shared Issue with article?

LETTERS: Molly Lamar will get education money to students

|
By Jason Lester
| The Sentinel Colorado Verified
Editor: Molly Lamar, a former public-school teacher, believes that all students, regardless of race, socioeconomic status or zip code should have an opportunity to achieve at grade level and to be productive citizens and achieve their goals. Her commitment to specialized academic support, targeted family engagement, enhanced educational rigor, and college/career preparedness will enrich performance in all school districts throughout Colorado.
Open in Who Shared Issue with article?

Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial

|
By Syed Hussain, Jason Lester, Richard Jackson, Matthew Gornall
| The Lancet Verified
Summary Background Recurrence is common after neoadjuvant chemotherapy and radical treatment for muscle-invasive bladder cancer. We investigated the effect of adding nintedanib to neoadjuvant chemotherapy on response and survival in muscle-invasive bladder cancer. Methods NEOBLADE was a parallel-arm, double-blind, randomised, placebo-controlled, phase 2 trial of neoadjuvant gemcitabine and cisplatin chemotherapy with nintedanib or placebo in locally advanced muscle-invasive bladder cancer.
Open in Who Shared Issue with article?
See all 11 articles